GGrantIndex
Sort

25,944 grants matching neurodegeneration

Stem cells and aging

$702,352
Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Intermittent Hypoxia Training: A Novel Therapy for Mild Cognitive Impairment

$702,028
Xiangrong Shi · University Of North Texas Hlth Sci Ctr · R01 · FY2024 · AG

Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease

$701,954
William C Mobley · University Of California, San Diego · R01 · FY2022 · AG

Core A: Administrative Core

$701,766
Douglas R Galasko · University Of California, San Diego · P50 · FY2017 · AG

Clinical Validation of Serum Neurofilament Light as a Biomarker of Traumatic Axonal Injury

$701,723
Ramon R Diaz-Arrastia · University Of Pennsylvania · U01 · FY2024 · NS

Brainstem-based imaging biomarkers of premanifest synucleinopathy

$701,536
Marta Bianciardi · Massachusetts General Hospital · R01 · FY2024 · AG

Core A: Administrative Core

$701,507
Douglas R Galasko · University Of California, San Diego · P50 · FY2018 · AG

Nutrient-Induced Mitochondrial Activity (NiMA): A Novel Lysosome to Mitochondria Signaling Pathway, its mechanisms and role in Alzheimer's Disease

$701,073
Andres M Norambuena · University Of Virginia · R01 · FY2024 · AG

Cellular And Molecular Pathogenesis Of Alzheimer

$700,959
Mark Mattson · National Institute On Aging · ZIA · FY2017 · AG

Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease

$700,828
Manu S Goyal · Washington University · R01 · FY2025 · AG

Gene Therapy Delivery for Age-related Neurodegenerative Diseases

$700,777
Rachel M Bailey · Ut Southwestern Medical Center · R01 · FY2025 · AG

Sleep abnormalities in Down Syndrome-related Alzheimer's disease

$700,717
Charles A Hoeffer · University Of Colorado · R01 · FY2023 · AG

Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial

$700,472
Kent E Hutchison · University Of Colorado Denver · R01 · FY2025 · AG

Brain Bank Core

$700,380
Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2021 · NS

TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION

$700,342
Bruce A Yankner · Harvard Medical School · T32 · FY2009 · AG

Sleep-dependent modulation of cerebrospinal fluid flow in aging and across genetic risk for Alzheimers disease

$700,219
Laura Diane Lewis · Boston University (Charles River Campus) · R01 · FY2021 · AG

Genetic Control of Programmed Cell Death (Apoptosis) and Compensatory Proliferation in Drosophila

$700,152
Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R35 · FY2017 · GM

Genetic Control of Programmed Cell Death (Apoptosis) and Compensatory Proliferation in Drosophila

$700,152
Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R35 · FY2019 · GM

Genetic Control of Programmed Cell Death (Apoptosis) and Compensatory Proliferation in Drosophila

$700,152
Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R35 · FY2020 · GM

Genetic Control of Programmed Cell Death (Apoptosis) and Compensatory Proliferation in Drosophila

$700,152
Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R35 · FY2018 · GM

Regulation of the Endo/Lysosomal pathway

$699,963
Rosa Puertollano · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage

$699,949
Christopher A Walsh · Boston Children'S Hospital · R01 · FY2025 · NS

Advancing novel therapies for optic neuropathy with a nonhuman primate model

$699,749
Sara Michelle Thomasy · University Of California At Davis · R01 · FY2024 · EY

Endolysosomal defects in secretory autophagy and microglial toxicity in FTD

$699,618
Eric J Huang · University Of California, San Francisco · R01 · FY2025 · AG

Genetic etiology of Amyotrophic Lateral Sclerosis

$699,575
Bryan Traynor · National Institute On Aging · ZIA · FY2012 · AG